CAPTRUST Financial Advisors’s CorMedix CRMD Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.9K	Buy	11,196 +511	+5%	+$4.04K	﹤0.01%	3060
2026 Q1	$72.6K	Buy	+10,685	New	+$79K	﹤0.01%	2854
2025 Q2	–	Sell	-11,013	Closed	-$67.8K	–	2530
2025 Q1	$67.8K	Sell	11,013 -103	-0.9%	-$1.07K	﹤0.01%	2266
2024 Q4	$90K	Buy	+11,116	New	+$111K	﹤0.01%	2211
2022 Q3	–	Sell	-1,679	Closed	-$7K	–	2474
2022 Q2	$7K	Buy	1,679 +179	+12%	+$665	﹤0.01%	3913
2022 Q1	$8K	Hold	1,500	–	–	﹤0.01%	3896
2021 Q4	$7K	Sell	1,500 -156	-9%	-$774	﹤0.01%	3896
2021 Q3	$8K	Sell	1,656 -785	-32%	-$4.57K	﹤0.01%	3723
2021 Q2	$17K	Buy	2,441 +941	+63%	+$7.49K	﹤0.01%	3210
2021 Q1	$15K	Buy	+1,500	New	+$15.8K	﹤0.01%	3184

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

CAPTRUST Financial Advisors's CRMD Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its CorMedix (CRMD) stake by 4.8% in Q2 2026, buying an estimated $4.04K and bringing the position to 11,196 shares worth $87.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3060.

CAPTRUST Financial Advisors first reported a position in CRMD in Q1 2021 and has held it in 10 quarters since. The position peaked at $90K in Q4 2024. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

CAPTRUST Financial Advisors held 11,196 shares of CorMedix worth $87.9K as of Q2 2026.
CAPTRUST Financial Advisors bought 511 CorMedix shares in Q2 2026, an estimated $4.04K.
CorMedix made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3060 holding.
CAPTRUST Financial Advisors first reported a position in CorMedix in Q1 2021 and has held it in 10 quarters since.
CAPTRUST Financial Advisors's CorMedix position peaked at $90K in Q4 2024.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.